Jiangsu Hengrui Pharma IPO Lockup - US$850m Cornerstone Release
Jiangsu Hengrui Pharmaceuticals (1276 HK), a China-based pharmaceutical company, raised around US$1.5bn in its H-share listing in May 2025. The...
433 Views
Hang Seng Index (HSI) Rebalance Preview: Inclusion Candidates for Dec25
We highlight 6 potential adds to the HSI in Dec. CATL is a high prob add and has a lock-up expiry tomorrow. Estimated turnover is 1.9% and trade is...
1.5k Views
Klook Pre-IPO - The Negatives - Disclosures Lagging
Klook (KLK US), a pan-regional experiences platform in Asia-Pacific, aims to raise around US$500m in its US listing. In this note, we talk about...
372 Views
CX Daily: China Should Launch Property Tax at āAppropriate Time,ā Ex-Finance Chief Says
TOP STORY China Should Launch Property Tax at āAppropriate Time,ā Ex-Finance Chief Says A nationwide property tax, though difficult to implement...
239 Views
ECM Weekly (17 November 2025) -Softcare, Northsand, Human Made, Lenskart, Pine Labs, Klook, Sagility
Aequitas Research's weekly update on the IPOs, placements, lockup expiry and other ECM linked events that were covered by the team over the past week.
334 Views